MedTrace Logo

Treatment of Primary Menstrual Pain With Kanion Capsule

NCT00523146 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2010-02-03

No results posted yet for this study

Summary

The objectives of this clinical trial are:

* To further study the safety of Kanion Capsule (GF) in primary dysmenorrhea subjects;
* To further evaluate the efficacy of GF in treatment of primary dysmenorrhea.

Conditions

  • Primary Dysmenorrhea

Interventions

DRUG

Kanion Capsule

Sponsors & Collaborators

  • Lianyungang Kanion Group, Ltd.

    lead INDUSTRY

Principal Investigators

  • Jun Shao, Ph.D. · Biokey Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2008-12-31
Completion
2009-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00523146 on ClinicalTrials.gov